Evidence map›Paper›PMID 20827454›Full record

ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2010

[Hepatocellular carcinoma and cholangiocarcinoma].

F Rauchfuss, H Scheuerlein, M Götz, Y Dittmar, R Voigt, M Heise, U Settmacher

Abstract read
PubMed Publisher
In one paragraph

Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

F RauchfussKlinik für Allgemein-, Viszeral- und Gefäßchirurgie, Friedrich-Schiller-Universität Jena, Universitätsklinikum Jena, Erlanger Allee 101, 07747, Jena, Deutschland. Falk.Rauchfuss@med.uni-jena.de
H Scheuerlein
M Götz
Y Dittmar
R Voigt
M Heise
U Settmacher

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma and cholangiocarcinoma are relatively rare tumors of the gastrointestinal tract in western Europe but their incidence has been increased in recent years. Newly diagnosed intrahepatic lesions or intrahepatic cholestasis require extensive laboratory tests and imaging studies in order to confirm the diagnosis of hepatocellular carcinoma, intrahepatic or extrahepatic cholangiocarcinoma. The treatment options range from liver resection or liver transplantation to conservative measures (in cases of non-resectable lesions). This review article aims to provide an overview on the diagnostic options and the subsequent treatment.

Indexed as

Bile Duct NeoplasmsBile Ducts, IntrahepaticBiopsyCarcinoma, HepatocellularCholangiocarcinomaCholangiopancreatography, Endoscopic RetrogradeCombined Modality TherapyContrast MediaFluorodeoxyglucose F18HepatectomyHumansLiver NeoplasmsLiver TransplantationMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray ComputedContrast MediaFluorodeoxyglucose F18

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.